Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank

Psychotic-like experiences, polygenic risk scores for schizophrenia, and structural properties of the salience, default mode, and central-executive networks in healthy participants from UK Biobank

(2020) C. Alloza et al.   Translational Psychiatry

Exploring Phenotypic and Genetic Overlap Between Cannabis Use and Schizotypy — Corrigendum

(2020) James Vaissiere et al.   Twin Research and Human Genetics

Use of Genetically Informed Methods to Clarify the Nature of the Association Between Cannabis Use and Risk for Schizophrenia

(2020) Nathan A. Gillespie et al.   JAMA Psychiatry

Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits

(2019) Sophie E. Legge et al.   JAMA Psychiatry

Components of genetic associations across 2,138 phenotypes in the UK Biobank highlight adipocyte biology

(2019) Yosuke Tanigawa et al.   Nature Communications

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial

(2018) Philip McGuire et al.   AMERICAN JOURNAL OF PSYCHIATRY

Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection

(2018) Antonio F. Pardiñas et al.   NATURE GENETICS

GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia

(2018) Joëlle A. Pasman et al.   NATURE NEUROSCIENCE

Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?

(2018) H. Valerie Curran et al.   PSYCHOLOGICAL MEDICINE

Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis

(2018) Sagnik Bhattacharyya et al.   JAMA Psychiatry

Genetic Predisposition vs Individual-Specific Processes in the Association Between Psychotic-like Experiences and Cannabis Use

(2018) Nicole R. Karcher et al.   JAMA Psychiatry

Cannabis use and risk of schizophrenia: a Mendelian randomization study

(2017) J Vaucher et al.   MOLECULAR PSYCHIATRY

The link between schizophrenia and substance use disorder: A unifying hypothesis

(2017) Jibran Y. Khokhar et al.   SCHIZOPHRENIA RESEARCH

Concurrent and Sustained Cumulative Effects of Adolescent Marijuana Use on Subclinical Psychotic Symptoms

(2016) Jordan Bechtold et al.   AMERICAN JOURNAL OF PSYCHIATRY

Human Laboratory Studies on Cannabinoids and Psychosis

(2016) Mohamed Sherif et al.   BIOLOGICAL PSYCHIATRY

Association Between Cannabis and Psychosis: Epidemiologic Evidence

(2016) Suzanne H. Gage et al.   BIOLOGICAL PSYCHIATRY

Deficits in striatal dopamine release in cannabis dependence

(2016) E van de Giessen et al.   MOLECULAR PSYCHIATRY

Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study

(2016) S. H. Gage et al.   PSYCHOLOGICAL MEDICINE

Genetic and Environmental Contributions to the Association Between Cannabis Use and Psychotic-Like Experiences in Young Adult Twins

(2016) Ragnar Nesvåg et al.   SCHIZOPHRENIA BULLETIN

Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis

(2016) Arianna Marconi et al.   SCHIZOPHRENIA BULLETIN

Adolescent Initiation of Cannabis Use and Early-Onset Psychosis

(2015) Kara S. Bagot et al.   Substance Abuse

Early Cannabis Use, Polygenic Risk Score for Schizophrenia and Brain Maturation in Adolescence

(2015) Leon French et al.   JAMA Psychiatry

Psychotic Experiences in the General Population

(2015) John J. McGrath et al.   JAMA Psychiatry

Epidemiological, Neurobiological, and Genetic Clues to the Mechanisms Linking Cannabis Use to Risk for Nonaffective Psychosis

(2014) Ruud van Winkel et al.   Annual Review of Clinical Psychology

How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆ 9 -Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia

(2014) Daniel Freeman et al.   SCHIZOPHRENIA BULLETIN

Psychotic Experiences and Psychotic Disorders at Age 18 in Relation to Psychotic Experiences at Age 12 in a Longitudinal Population-Based Cohort Study

(2013) Stanley Zammit et al.   AMERICAN JOURNAL OF PSYCHIATRY

Reasons for cannabis use among youths at ultra high risk for psychosis

(2013) Kelly E. Gill et al.   Early Intervention in Psychiatry

Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users

(2013) M. Di Forti et al.   SCHIZOPHRENIA BULLETIN

Persecutory ideation and a history of cannabis use

(2013) Daniel Freeman et al.   SCHIZOPHRENIA RESEARCH

Cannabis Use and Earlier Onset of Psychosis

(2011) Matthew Large et al.   ARCHIVES OF GENERAL PSYCHIATRY

Cannabis with high cannabidiol content is associated with fewer psychotic experiences

(2011) Christian D. Schubart et al.   SCHIZOPHRENIA RESEARCH

Delusions and metacognition in patients with schizophrenia

(2011) Nicolas Bruno et al.   Cognitive Neuropsychiatry

Toward a neurobiology of delusions

(2010) P.R. Corlett et al.   PROGRESS IN NEUROBIOLOGY

Domains of Awareness in Schizophrenia

(2010) J. Gilleen et al.   SCHIZOPHRENIA BULLETIN

High-potency cannabis and the risk of psychosis

(2009) Marta Di Forti et al.   BRITISH JOURNAL OF PSYCHIATRY

Cannabinoid Modulation of Amygdala Reactivity to Social Signals of Threat in Humans

(2008) K. L. Phan et al.   JOURNAL OF NEUROSCIENCE

Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia

(2008) Paul C. Fletcher et al.   NATURE REVIEWS NEUROSCIENCE

Gene-Environment Interplay Between Cannabis and Psychosis

(2008) C. Henquet et al.   SCHIZOPHRENIA BULLETIN